share_log

ZIVO Bioscience, Inc. (NASDAQ:ZIVOW) Sees Large Decline in Short Interest

Defense World ·  Dec 30, 2022 01:21

ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) saw a significant decrease in short interest in December. As of December 15th, there was short interest totalling 4,800 shares, a decrease of 25.0% from the November 30th total of 6,400 shares. Based on an average daily volume of 5,700 shares, the days-to-cover ratio is presently 0.8 days.

ZIVO Bioscience Stock Up 18.5 %

Shares of ZIVOW stock opened at $0.77 on Friday. The stock has a 50-day simple moving average of $0.68 and a 200 day simple moving average of $0.76. ZIVO Bioscience has a fifty-two week low of $0.23 and a fifty-two week high of $1.52.

Get ZIVO Bioscience alerts:

Hedge Funds Weigh In On ZIVO Bioscience

A hedge fund recently raised its stake in ZIVO Bioscience stock. Warberg Asset Management LLC lifted its stake in ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) by 442.0% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 84,654 shares of the company's stock after purchasing an additional 69,034 shares during the quarter. Warberg Asset Management LLC's holdings in ZIVO Bioscience were worth $51,000 as of its most recent filing with the Securities & Exchange Commission.

About ZIVO Bioscience

(Get Rating)

ZIVO Bioscience, Inc is a Michigan-based biotech/agtech company dedicated to harnessing the immune health and nutritional benefits of bioactive compounds derived from its proprietary algal cultures. The development pipeline includes natural products for use as dietary supplements and functional food ingredients, as well as innovative, biologically derived and synthesized candidates designed to deliver medicinal and pharmaceutical benefits for humans and animals, with a specific focus on modulating the immune and inflammatory response.

Featured Stories

  • Get a free copy of the StockNews.com research report on ZIVO Bioscience (ZIVOW)
  • Should You Warm up to Generac Stock for the Winter?
  • Is Kintara Therapeutics A Hidden Gem?
  • 3 High-Yield Dividend Stocks to Hold for the Long Haul
  • Cal-Maine Posts Record Quarter, Remain CALM Income Investors
  • Tesla Stock: What the Bulls and the Bears Are Getting Wrong

Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment